Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VA › VIRGINIA BEACH › SENTARA PRINCESS ANNE HOSPITAL

SENTARA PRINCESS ANNE HOSPITAL

NPI: 1528028396 · VIRGINIA BEACH, VA 23456 · Cardiac Rehabilitation Clinic/Center · NPI assigned 03/25/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official HANCOCK, MELINDA controls 20+ related entities in our dataset. Read more

$37.50M
Total Medicaid Paid
1,097,962
Total Claims
735,384
Beneficiaries
277
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHANCOCK, MELINDA (CFO)
Parent OrganizationSENTARA HEALTHCARE
NPI Enumeration Date03/25/2006

Related Entities

Other providers sharing the same authorized official: HANCOCK, MELINDA

ProviderCityStateTotal Paid
SENTARA HOSPITALS NORFOLK VA $88.20M
SENTARA HOSPITALS NORFOLK VA $79.69M
SENTARA HOSPITALS HAMPTON VA $78.52M
POTOMAC HOSPITAL CORPORATION OF PRINCE WILLIAM WOODBRIDGE VA $59.17M
SENTARA HOSPITALS SUFFOLK VA $57.85M
SENTARA RMH MEDICAL CENTER HARRISONBURG VA $52.95M
SENTARA HOSPITALS VIRGINIA BEACH VA $52.40M
MARTHA JEFFERSON HOSPITAL CHARLOTTESVILLE VA $26.95M
HALIFAX REGIONAL HOSPITAL, INC. SOUTH BOSTON VA $23.28M
SENTARA HOSPITALS WILLIAMSBURG VA $21.89M
SENTARA ALBEMARLE REGIONAL MEDICAL CENTER ELIZABETH CITY NC $13.82M
SENTARA REFERENCE LAB SOLUTIONS, LLC NORFOLK VA $4.74M
HALIFAX REGIONAL HOSPITAL, INC SOUTH BOSTON VA $1.61M
HALIFAX REGIONAL HOSPITAL, INC NATHALIE VA $348K
HALIFAX REGIONAL HOSPITAL, INC SOUTH BOSTON VA $336K
HALIFAX REGIONAL HOSPITAL, INC CHASE CITY VA $298K
HALIFAX REGIONAL HOSPITAL, INC CLARKSVILLE VA $265K
SENTARA HOSPITALS NORFOLK VA $171K
HALIFAX REGIONAL HOSPITAL, INC SOUTH BOSTON VA $170K
SENTARA HOSPITALS NORFOLK VA $128K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 94,439 $2.13M
2019 143,008 $3.28M
2020 130,213 $4.68M
2021 173,833 $6.02M
2022 193,340 $6.74M
2023 221,003 $8.79M
2024 142,126 $5.86M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 44,048 36,523 $6.88M
99284 Emergency department visit for the evaluation and management, high severity 33,024 26,818 $5.32M
96361 Intravenous infusion, hydration; each additional hour 13,162 9,570 $3.77M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 17,709 14,663 $3.00M
74177 Computed tomography, abdomen and pelvis; with contrast material 9,358 8,008 $1.78M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 35,544 9,322 $1.74M
99282 Emergency department visit for the evaluation and management, low to moderate severity 10,270 9,064 $1.56M
70450 Computed tomography, head or brain; without contrast material 8,136 6,851 $1.41M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 9,698 2,517 $1.29M
71275 Computed tomographic angiography, chest, with contrast material 3,025 2,654 $755K
59025 Fetal non-stress test 3,476 2,655 $646K
G0378 Hospital observation service, per hour 2,613 1,890 $561K
97530 Therapeutic activities, direct patient contact, each 15 minutes 15,587 5,121 $544K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 21,090 5,934 $489K
97161 4,021 3,568 $438K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,650 1,461 $427K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,352 2,028 $416K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 3,039 2,622 $341K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 903 814 $282K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,091 694 $257K
97162 2,385 2,073 $240K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,310 4,529 $235K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 5,146 3,254 $228K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,435 2,174 $218K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 14,781 4,500 $195K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,308 2,003 $186K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 340 298 $185K
77063 Screening digital breast tomosynthesis, bilateral 4,249 4,051 $175K
80048 Basic metabolic panel (calcium, ionized) 45,088 32,819 $173K
J3490 Unclassified drugs 149,568 40,565 $168K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 13,283 8,709 $166K
59050 682 486 $153K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 794 736 $149K
71046 Radiologic examination, chest; 2 views 20,150 17,214 $141K
97535 Self-care/home management training, each 15 minutes 3,989 2,382 $125K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,655 1,425 $120K
77067 Screening mammography, bilateral, including computer-aided detection 4,501 4,273 $113K
76830 Ultrasound, transvaginal 1,663 1,487 $112K
93971 1,241 1,046 $104K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 2,378 1,948 $103K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 4,095 1,165 $103K
0240U 1,914 1,770 $101K
93017 1,201 1,043 $97K
97165 1,066 925 $96K
76642 656 549 $76K
70551 Magnetic resonance imaging, brain; without contrast material 374 339 $76K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 25,144 20,540 $74K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 943 892 $69K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7,246 6,328 $65K
72141 304 289 $65K
71250 869 775 $57K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,053 901 $49K
72125 Computed tomography, cervical spine; without contrast material 1,410 1,225 $47K
64483 61 41 $46K
97116 2,077 986 $45K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 188 162 $42K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2,424 2,078 $40K
70491 203 190 $39K
80047 11,039 9,373 $37K
64493 45 39 $33K
83880 4,132 3,382 $32K
94060 572 517 $31K
10060 230 200 $31K
85379 6,122 5,358 $31K
80076 14,940 12,322 $30K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 46,988 35,807 $29K
80053 Comprehensive metabolic panel 4,935 3,966 $26K
76536 227 216 $25K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 25,309 20,241 $25K
97016 785 201 $24K
84484 16,356 9,560 $24K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,005 1,422 $21K
76770 151 141 $21K
94726 713 647 $20K
97113 563 176 $20K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,813 1,642 $19K
93970 159 135 $19K
71045 Radiologic examination, chest; single view 6,530 5,524 $19K
94729 763 692 $18K
70486 328 303 $18K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 2,090 1,966 $16K
97166 112 104 $16K
90715 817 754 $15K
82962 13,949 5,131 $15K
72110 1,095 952 $14K
99281 Emergency department visit for the evaluation and management, self-limited or minor 111 94 $14K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 4,252 3,766 $14K
73130 1,484 1,245 $14K
73030 1,341 1,143 $13K
85027 7,278 5,342 $13K
73564 2,073 1,659 $13K
73630 2,249 1,844 $12K
77066 Tomosynthesis, mammo 292 279 $12K
84703 10,019 8,718 $12K
86850 2,697 2,326 $12K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 727 689 $10K
96375 Therapeutic injection; each additional sequential IV push 17,764 13,419 $10K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 751 677 $10K
29125 76 66 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9,849 5,788 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg 19,450 14,838 $9K
86900 3,978 3,261 $9K
73610 1,826 1,549 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 99 95 $9K
93976 320 277 $9K
85014 6,584 5,462 $9K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 298 265 $8K
87086 Culture, bacterial; quantitative colony count, urine 8,924 7,443 $8K
77065 Tomosynthesis, mammo 209 180 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 16,186 12,600 $7K
81025 12,374 10,699 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 620 539 $7K
64635 19 12 $7K
81001 22,872 18,979 $7K
20610 68 51 $6K
96376 7,457 3,916 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 28 24 $6K
J3010 Injection, fentanyl citrate, 0.1 mg 6,664 4,897 $6K
64494 18 14 $6K
64495 17 13 $6K
83605 4,746 3,713 $6K
94799 1,992 1,108 $6K
97163 27 25 $6K
73502 545 486 $5K
87040 1,731 805 $5K
83036 Hemoglobin; glycosylated (A1C) 1,598 1,369 $5K
36415 Collection of venous blood by venipuncture 6,286 5,116 $5K
76700 Ultrasound, abdominal, real time with image documentation; complete 27 24 $5K
84443 Thyroid stimulating hormone (TSH) 2,808 2,434 $5K
97750 273 225 $5K
74018 434 372 $4K
27096 15 13 $4K
85610 4,310 3,284 $4K
64636 20 12 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 7,184 6,271 $4K
83690 12,417 10,235 $4K
81003 12,918 10,686 $4K
85018 1,780 1,418 $4K
73110 534 464 $3K
82565 2,195 1,803 $3K
C1729 Catheter, drainage 622 541 $3K
J2060 Injection, lorazepam, 2 mg 2,746 2,071 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,480 8,612 $3K
83735 3,998 2,817 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,553 2,069 $3K
77080 46 39 $3K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 20 13 $3K
76942 28 26 $3K
84702 3,143 2,458 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 993 857 $3K
80061 Lipid panel 1,094 932 $3K
64450 14 13 $2K
97802 16 16 $2K
86901 3,979 3,259 $2K
71271 27 26 $2K
12011 13 13 $2K
85730 1,441 1,172 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 4,005 3,599 $2K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 3,806 3,317 $2K
J2704 Injection, propofol, 10 mg 3,948 3,554 $2K
90686 198 175 $2K
87210 6,208 5,406 $2K
72100 111 103 $2K
72050 83 77 $2K
87631 55 51 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 6,922 6,106 $1K
J1170 Injection, hydromorphone, up to 4 mg 6,863 4,079 $1K
87077 3,382 2,821 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,528 1,194 $1K
80143 191 166 $1K
J2270 Injection, morphine sulfate, up to 10 mg 7,549 5,445 $1K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 371 347 $1K
88304 389 344 $1K
J0690 Injection, cefazolin sodium, 500 mg 3,245 2,303 $1K
87428 1,900 1,720 $1K
84145 213 160 $1K
82077 3,318 2,814 $966.69
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 27 24 $964.05
76870 14 13 $927.99
82553 235 153 $848.94
87081 2,569 2,357 $828.91
J1200 Injection, diphenhydramine hcl, up to 50 mg 3,568 2,748 $800.51
J1644 Injection, heparin sodium, per 1000 units 5,108 1,854 $762.24
73140 197 175 $751.78
G0008 Administration of influenza virus vaccine 672 500 $730.47
J2250 Injection, midazolam hydrochloride, per 1 mg 4,334 3,846 $693.06
94618 15 14 $693.06
87186 2,045 1,675 $606.43
73562 61 37 $602.44
73590 128 105 $585.00
82310 2,119 1,888 $558.34
80179 142 122 $517.24
82570 537 449 $462.45
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 886 756 $461.98
84439 78 63 $441.33
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 166 140 $401.95
J0696 Injection, ceftriaxone sodium, per 250 mg 3,845 2,917 $396.87
J1630 Injection, haloperidol, up to 5 mg 1,079 908 $372.09
51798 66 37 $361.05
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 12 12 $350.50
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 1,515 1,228 $278.65
72072 13 13 $274.11
J2550 Injection, promethazine hcl, up to 50 mg 2,118 1,571 $273.78
J2785 Injection, regadenoson, 0.1 mg 181 160 $258.18
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 882 776 $200.18
84550 665 544 $185.61
73080 49 39 $168.71
83615 539 437 $136.71
82550 539 420 $122.14
84156 313 258 $118.17
C9290 Injection, bupivacaine liposome, 1 mg 32 26 $115.17
80164 17 12 $111.60
84100 296 223 $100.06
80069 41 26 $88.97
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 81 77 $73.54
J8597 Antiemetic drug, oral, not otherwise specified 137 113 $63.30
J1815 Injection, insulin, per 5 units 349 190 $62.56
J0780 Injection, prochlorperazine, up to 10 mg 1,086 925 $60.77
82607 16 13 $49.29
A9577 Injection, gadobenate dimeglumine (multihance), per ml 56 37 $45.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 634 501 $42.88
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 138 126 $42.25
J3535 Drug administered through a metered dose inhaler 56 46 $37.85
J2765 Injection, metoclopramide hcl, up to 10 mg 556 467 $34.98
87070 220 193 $33.66
87205 389 302 $32.95
90694 15 13 $25.17
82746 14 12 $24.29
A9575 Injection, gadoterate meglumine, 0.1 ml 2,204 1,618 $21.44
87807 44 37 $17.34
82803 43 28 $14.61
87340 12 12 $13.14
82330 112 89 $12.98
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 112 97 $11.97
85652 15 12 $11.83
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 152 130 $11.14
82272 63 54 $10.99
84132 97 69 $8.75
82043 14 13 $8.72
80320 24 22 $8.13
J7030 Infusion, normal saline solution , 1000 cc 71 51 $7.73
J1940 Injection, furosemide, up to 20 mg 81 54 $6.37
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 58 39 $2.60
J0360 Injection, hydralazine hcl, up to 20 mg 83 56 $1.82
J3360 Injection, diazepam, up to 5 mg 70 54 $1.71
J0171 Injection, adrenalin, epinephrine, 0.1 mg 14 13 $1.50
J1596 Injection, glycopyrrolate, 0.1 mg 81 79 $0.31
C1769 Guide wire 579 484 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 294 217 $0.00
A9585 Injection, gadobutrol, 0.1 ml 173 119 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 198 168 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 372 325 $0.00
90688 51 33 $0.00
A6223 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing 27 24 $0.00
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units 106 40 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 50 40 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 44 24 $0.00
99234 31 27 $0.00
73090 14 12 $0.00
74022 29 14 $0.00
J3480 Injection, potassium chloride, per 2 meq 18 12 $0.00
88342 28 24 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 152 121 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 13 13 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 359 297 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 46 27 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 279 249 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 77 45 $0.00
J3370 Injection, vancomycin hcl, 500 mg 151 92 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 35 25 $0.00
90756 25 19 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 72 68 $0.00
90653 59 39 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 93 81 $0.00
82009 15 12 $0.00
J1171 Injection, hydromorphone, 0.1 mg 290 173 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 32 27 $0.00